Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations

In recent years, therapeutic advances, together with new medication sequences and combinations, have improved outcomes for prostate cancer. For a long time, androgen deprivation therapy (ADT) has been the standard of care for newly diagnosed, metastatic prostate cancer, first as a standalone therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Clin Risk Manag
Main Authors: Castellan, Pietro, Marchioni, Michele, Castellucci, Roberto, De Francesco, Piergustavo, Iantorno, Romina, Schips, Luigi, Cindolo, Luca
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6287515/
https://ncbi.nlm.nih.gov/pubmed/30584309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S159824
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados